Parthenon LLC Has $1.87 Million Stake in Colgate-Palmolive (CL)

Parthenon LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,418 shares of the company’s stock after selling 300 shares during the quarter. Parthenon LLC’s holdings in Colgate-Palmolive were worth $1,870,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Farmers & Merchants Trust Co of Chambersburg PA grew its stake in Colgate-Palmolive by 46.2% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 950 shares of the company’s stock valued at $57,000 after buying an additional 300 shares during the last quarter. Moody National Bank Trust Division acquired a new position in Colgate-Palmolive in the 4th quarter valued at $94,000. Price Capital Management Inc. acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $121,000. O Brien Wealth Partners LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $123,000. Finally, IMS Capital Management grew its stake in Colgate-Palmolive by 631.6% in the 3rd quarter. IMS Capital Management now owns 2,085 shares of the company’s stock valued at $140,000 after buying an additional 1,800 shares during the last quarter. Institutional investors own 74.47% of the company’s stock.

NYSE CL opened at $65.05 on Friday. The firm has a market capitalization of $56.42 billion, a price-to-earnings ratio of 21.90, a P/E/G ratio of 4.20 and a beta of 0.78. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $73.14.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.01. The company had revenue of $3.81 billion for the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The business’s quarterly revenue was down 2.1% on a year-over-year basis. During the same period last year, the business posted $0.75 EPS. Sell-side analysts predict that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 15th. Shareholders of record on Wednesday, January 23rd will be given a $0.42 dividend. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $1.68 annualized dividend and a yield of 2.58%. Colgate-Palmolive’s dividend payout ratio is 56.57%.

A number of research analysts recently issued reports on CL shares. Wells Fargo & Co lowered their target price on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 17th. UBS Group set a $71.00 target price on shares of Colgate-Palmolive and gave the company a “buy” rating in a research note on Wednesday, October 17th. SunTrust Banks lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the company from $80.00 to $65.00 in a research note on Friday, October 26th. JPMorgan Chase & Co. lowered shares of Colgate-Palmolive from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $61.00 to $54.00 in a research note on Monday, October 29th. Finally, Citigroup lowered their target price on shares of Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a research note on Monday, October 29th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $65.00.

In other Colgate-Palmolive news, Director John T. Cahill sold 5,780 shares of the firm’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $64.46, for a total value of $372,578.80. Following the sale, the director now directly owns 27,820 shares in the company, valued at approximately $1,793,277.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.02% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Parthenon LLC Has $1.87 Million Stake in Colgate-Palmolive (CL)” was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.com-unik.info/2019/02/03/parthenon-llc-has-1-87-million-stake-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Read More: Bid-Ask Spread

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit